Longitudinal analysis to determine persistence of T cell responses induced by SARS-CoV-2 vaccination, natural infection with SARS-CoV-2, and human common cold coronaviruses
纵向分析以确定 SARS-CoV-2 疫苗接种、SARS-CoV-2 自然感染和人类普通感冒冠状病毒诱导的 T 细胞反应的持续性
基本信息
- 批准号:10619611
- 负责人:
- 金额:$ 65.65万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2015
- 资助国家:美国
- 起止时间:2015-06-15 至 2027-05-31
- 项目状态:未结题
- 来源:
- 关键词:2019-nCoVAddressAgeAntigensAuthorization documentationBlood specimenCD8-Positive T-LymphocytesCOVID-19 vaccinationCOVID-19 vaccineCellsClinicalClone CellsCommon ColdCommunicable DiseasesCoronavirusCross-Sectional StudiesCytomegalovirusDataDoseEnrollmentEthnic OriginEvaluationExposure toHumanImmuneImmunizationIndividualInfectionInfluenzaInvestigationLongitudinal cohortMeasuresMolecularPathogenicityPatternPersonsPertussisPhenotypePropertyRNARespiratory Tract DiseasesSARS-CoV-2 antigenSARS-CoV-2 infectionSamplingSequence AnalysisSeverity of illnessT cell clonalityT cell receptor repertoire sequencingT cell responseT memory cellT-Cell ReceptorT-LymphocyteTestingTimeVaccinatedVaccinationVaccineeVaccinesVirusYellow Feverantigen-specific T cellsauthoritybiomarker panelcohortcross reactivitylongitudinal analysispathogenpre-pandemicrecruitrespiratory pathogenresponsesexsingle-cell RNA sequencingtranscriptometranscriptomicsunvaccinatedvaccination outcomevaccine platformvaccine trial
项目摘要
Project Summary: Project 1
The current LJI HIPC Proposal focuses on common pathogens causing infectious diseases of the respiratory
tract. Here in Project 1, our focus is to define changes of antigen-specific T cell responses to SARS-CoV-2
vaccination over time, up to 3 years post vaccination; and compare them to those observed in natural infection
or previously-infected, but now recently-vaccinated subjects.
We will examine T cell phenotypes defined by cytometric analysis of reference panels of markers. T cell sub-
populations defined by transcriptomes of single-cells, and T cell clonality defined by single-cell T cell receptor
(TCR) sequence analysis. These unbiased studies will define features associated with the magnitude and
persistence of antigen-specific T cell responses.
The data generated in the context of SARS-CoV-2 will then be compared the data to T cell responses induced
by natural infection with common cold coronaviruses (CCC). This will provide a comparator with other much less
pathogenic coronaviruses.
Our studies will further detail and compare the results of vaccination with different SARS-CoV-2 vaccine
platforms (Moderna, Pfizer, J&J and others that might be authorized). In parallel, we will investigate samples
from two studies involving two commonly utilized vaccines, namely those against Yellow Fever and Pertussis.
Finally, our studies will also provide a large cross-sectional cohort, to address, on one hand, differences in
disease severity, ranging from mild to moderate to severe, and the impact of variables such as age, sex, ethnicity,
disease severity, and exposure to CCC viruses on the magnitude and persistence of vaccine-induced T cell
responses.
项目概要:项目1
LJI重债穷国倡议目前的提案侧重于引起呼吸道传染病的常见病原体,
道。在项目1中,我们的重点是确定抗原特异性T细胞对SARS-CoV-2应答的变化
随着时间的推移,接种疫苗后最多3年;并将其与自然感染中观察到的结果进行比较
或者之前感染过但最近接种过疫苗的人
我们将检查T细胞表型定义的细胞计数分析参考面板的标志物。T细胞亚群
由单细胞转录组定义的群体,以及由单细胞T细胞受体定义的T细胞克隆性
(TCR)序列分析这些无偏见的研究将定义与震级相关的特征,
抗原特异性T细胞应答的持久性。
然后将SARS-CoV-2背景下产生的数据与诱导的T细胞应答进行比较。
普通感冒冠状病毒(CCC)的自然感染。这将提供一个比较器与其他少得多
致病性冠状病毒。
我们的研究将进一步详细说明和比较不同SARS-CoV-2疫苗的接种结果
平台(Moderna、辉瑞、强生和其他可能获得授权的公司)。同时,我们将调查样本
两项研究涉及两种常用疫苗,即黄热病和百日咳疫苗。
最后,我们的研究还将提供一个大型的横断面队列,一方面,
疾病严重程度,从轻度到中度到重度,以及年龄,性别,种族,
疾病严重程度和暴露于CCC病毒对疫苗诱导的T细胞免疫应答的强度和持续性的影响
应答
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Alessandro Sette其他文献
Alessandro Sette的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Alessandro Sette', 18)}}的其他基金
Human immune signatures of Dengue virus and Mycobacterium Tuberculosis exposure in infection, disease and vaccination
感染、疾病和疫苗接种中登革热病毒和结核分枝杆菌暴露的人体免疫特征
- 批准号:
10265651 - 财政年份:2020
- 资助金额:
$ 65.65万 - 项目类别:
Human immune signatures of Dengue virus and Mycobacterium Tuberculosis exposure in infection, disease and vaccination
感染、疾病和疫苗接种中登革热病毒和结核分枝杆菌暴露的人体免疫特征
- 批准号:
10228367 - 财政年份:2020
- 资助金额:
$ 65.65万 - 项目类别:
Human immune signatures of Dengue virus and Mycobacterium Tuberculosis exposure in infection, disease and vaccination
感染、疾病和疫苗接种中登革热病毒和结核分枝杆菌暴露的人体免疫特征
- 批准号:
10056696 - 财政年份:2020
- 资助金额:
$ 65.65万 - 项目类别:
Large Scale T Cell Epitope Discovery: Global identification of epitopes derived from Zika (ZIKV) and Chikungunya (CHIKV) viruses following natural infection and vaccination
大规模 T 细胞表位发现:在自然感染和疫苗接种后对寨卡病毒 (ZIKV) 和基孔肯雅病毒 (CHIKV) 衍生的表位进行全面鉴定
- 批准号:
10020640 - 财政年份:2019
- 资助金额:
$ 65.65万 - 项目类别:
Large Scale T Cell Epitope Discovery: Genome-wide characterization of T cell epitopes from Bordetella pertussis in vaccination and natural infection
大规模 T 细胞表位发现:疫苗接种和自然感染中百日咳博德特氏菌 T 细胞表位的全基因组特征
- 批准号:
10616655 - 财政年份:2019
- 资助金额:
$ 65.65万 - 项目类别:
Large Scale T Cell Epitope Discovery: Genome-wide characterization of T cell epitopes from Bordetella pertussis in vaccination and natural infection
大规模 T 细胞表位发现:疫苗接种和自然感染中百日咳博德特氏菌 T 细胞表位的全基因组特征
- 批准号:
10439413 - 财政年份:2019
- 资助金额:
$ 65.65万 - 项目类别:
Mechanisms of differential responses to whole cell and acellular pertussis vaccination
全细胞和无细胞百日咳疫苗接种的差异反应机制
- 批准号:
10580758 - 财政年份:2019
- 资助金额:
$ 65.65万 - 项目类别:
Mechanisms of differential responses to whole cell and acellular pertussis vaccination
全细胞和无细胞百日咳疫苗接种的差异反应机制
- 批准号:
10366648 - 财政年份:2019
- 资助金额:
$ 65.65万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 65.65万 - 项目类别:
Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 65.65万 - 项目类别:
Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 65.65万 - 项目类别:
Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 65.65万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 65.65万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 65.65万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 65.65万 - 项目类别:
EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 65.65万 - 项目类别:
Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 65.65万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 65.65万 - 项目类别:
Research Grant